Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Hong Kong · Delayed Price · Currency is HKD 6.90
-0.02 (-0.29%)
Jul 31, 2026, 4:08 PM HKT
HKG:3613 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, HKG:3613 stock has a consensus rating of "Buy" and an average price target of $10.25. The average 1-year stock price forecast is 48.55% higher than the current stock price, while the lowest is $10.00 (+44.93%) and the highest is $10.50 (+52.17%).
Price Target: $10.25 (+48.55%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jun 19, 2026.
Analyst Ratings
The average analyst rating for HKG:3613 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Aug '25 | Sep '25 | Dec '25 | Mar '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $10.50 | Buy | Maintains | $10.50 | +52.17% | Jun 19, 2026 |
Financial Forecast
Revenue This Year
1.67B
from 1.51B
Increased by 10.61%
Revenue Next Year
1.87B
from 1.67B
Increased by 11.60%
EPS This Year
0.53
from 0.47
Increased by 12.77%
EPS Next Year
0.59
from 0.53
Increased by 11.32%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is HKD.